| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 03/28/2001 | EP1086230A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs |
| 03/28/2001 | EP1086207A1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 03/28/2001 | EP1086131A1 Cyclic somatostatin analogs |
| 03/28/2001 | EP1086125A1 Respiratory nitrate reductase alpha subunit |
| 03/28/2001 | EP1086124A1 Novel cyclosporins |
| 03/28/2001 | EP1086112A2 1-galactose derivatives |
| 03/28/2001 | EP1086109A1 Process for preparing crystalline salts of amoxycillin |
| 03/28/2001 | EP1086106A1 Furopyridine derivatives and their therapeutical use |
| 03/28/2001 | EP1086104A1 Fused phenoxymethyl carbapenem antibacterials |
| 03/28/2001 | EP1086101A1 Beta-carboline compounds |
| 03/28/2001 | EP1086100A1 Pyrrole derivatives, preparation method and pharmaceutical compositions containing same |
| 03/28/2001 | EP1086099A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 03/28/2001 | EP1086094A1 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity |
| 03/28/2001 | EP1086091A1 Hiv integrase inhibitors |
| 03/28/2001 | EP1086087A1 Crystalline efavirenz |
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 03/28/2001 | EP1086085A1 INHIBITORS OF p38 |
| 03/28/2001 | EP1086080A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 03/28/2001 | EP1086076A1 Sulfonamide inhibitors of aspartyl protease |
| 03/28/2001 | EP1085921A2 Antimicrobial alcohol gel pre-operative skin-preparation delivery systems |
| 03/28/2001 | EP1085904A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085872A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-$g(k)B |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085848A2 Inhibitors of transcription factor nf-kappa b |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085804A1 Method and composition for the treatment of epidermal irritations and infections |
| 03/28/2001 | EP0910428A4 Photopheresis treatment of chronic hcv infections |
| 03/28/2001 | EP0831897B1 In ovo vaccination against coccidiosis |
| 03/28/2001 | CN1289339A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 03/28/2001 | CN1289335A Azolo triazizes and pyrimidines |
| 03/28/2001 | CN1289334A Benzothiadiazoles and derivatives |
| 03/28/2001 | CN1289331A Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 03/28/2001 | CN1289322A Hydroxamic and carboxylic acid derivatives |
| 03/28/2001 | CN1289254A Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions |
| 03/28/2001 | CN1289248A Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 03/28/2001 | CN1288950A Preparation and application of monocloning antibody based on DNA immunity |
| 03/28/2001 | CN1288892A Preparation and application of dihydromyricetrin |
| 03/28/2001 | CN1288885A Alkylating method of hindered sulfonic acid |
| 03/28/2001 | CN1288747A Composite medicine containing dihydromyricetrin |
| 03/28/2001 | CN1288734A Fast-acting composite spray for cold and its preparation |
| 03/28/2001 | CN1288725A Preparation of serial veterinary injecta products |
| 03/28/2001 | CN1063747C Quinotone and naphthyridonecarboxylic acid derivatives |
| 03/28/2001 | CN1063646C Sugar-less particles for treating infant's cold and preparation method |
| 03/27/2001 | US6207855 Stable no-delivering compounds |
| 03/27/2001 | US6207823 Antibiotic; antibiotic resistant infections |
| 03/27/2001 | US6207820 Solid phase synthesis by linking acceptor monosaccharide to support forming carboxylate or carboxyamide linkage, covalently linking donor saccharide by o-glycosidic linkage, coupling lipophosphoglycerate mimetic, cleaving from support |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207801 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
| 03/27/2001 | US6207709 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid compounds having kynurenine-3-hydroxy base inhibitory activity |
| 03/27/2001 | US6207703 Mucoadministering to airways formulation comprising antifungal agent to reduce or eliminate symptoms of asthma |
| 03/27/2001 | US6207688 Treating multi-drug resistant, non-nucleoside reverse transcriptase resistant, and therapy naive hiv infection by administering phenethyl-thiourea derivative |
| 03/27/2001 | US6207687 Substituted imidazoles having cytokine inhibitory activity |
| 03/27/2001 | US6207675 For prophylaxis and therapy of diseases in which are involved viruses of the herpes family and/or cytokines in particular tumor nercosis factor-alpha |
| 03/27/2001 | US6207670 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 03/27/2001 | US6207653 Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 03/27/2001 | US6207649 Nucleoside analogs and uses in treating disease |
| 03/27/2001 | US6207647 Polynucleotides and polypeptides of the rat family, referred to as ?rata?; treatment of chlamydia infections |
| 03/27/2001 | US6207646 Immunostimulatory nucleic acid molecules |
| 03/27/2001 | US6207457 Targeted nucleotide sequence delivery and integration system |
| 03/27/2001 | US6207453 A replication-defective adeno-associated virus vector containing exogenous dna bound to a dna which codes for a rep protein; gene therapy |
| 03/27/2001 | US6207449 Nucleotide sequence of gene; hybridization probes for detection; drug screening for bactericides, bacteriostats and antibiotics |
| 03/27/2001 | US6207411 Bacteriocins |
| 03/27/2001 | US6207200 Administering an antiviral protein to patient infected with human immunodefficiency virus type i |
| 03/27/2001 | US6207197 Microsphere comprising a drug-containing inner core, water insoluble polymeric rate controlling layer, and a bioadhesive outer layer of cationic polymer; treatment of helicobacter pylori |
| 03/27/2001 | US6207169 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 03/27/2001 | US6207168 Vaccine composition for herpes simplex virus and methods of using |
| 03/27/2001 | US6207166 Veterinary medicine |
| 03/27/2001 | US6207165 Polynucleotide formula against porcine reproductive and respiratory pathologies |
| 03/27/2001 | US6207162 AspS from Chlamydia trachomatis |
| 03/27/2001 | US6207161 Genetic engineering |
| 03/27/2001 | US6207157 Conjugate vaccine for nontypeable Haemophilus influenzae |
| 03/27/2001 | CA2135200C Canine coronavirus s gene and uses therefor |
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/27/2001 | CA2007499C Treatment methods and vaccines for stimulating an immune response |
| 03/22/2001 | WO2001020028A1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes |
| 03/22/2001 | WO2001020013A2 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | WO2001019993A2 Virulence genes of m. marinum and m. tuberculosis |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019977A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 03/22/2001 | WO2001019974A2 Recombinant microorganisms |
| 03/22/2001 | WO2001019973A2 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | WO2001019960A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | WO2001019866A1 Dipeptidyl peptidases |
| 03/22/2001 | WO2001019852A2 Methods of peptide preparation |
| 03/22/2001 | WO2001019850A2 Nrage nucleic acids and polypeptides and uses thereof |
| 03/22/2001 | WO2001019841A1 Charge-modified nucleic acid terminators |
| 03/22/2001 | WO2001019831A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019830A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019829A2 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | WO2001019828A2 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | WO2001019825A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | WO2001019822A1 Antiviral agents |
| 03/22/2001 | WO2001019819A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019814A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019811A2 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv |
| 03/22/2001 | WO2001019801A1 Bioactive substance containing derivatives of 2-amino-6-aryloxypyrimidines and intermediary products of synthesis thereof |
| 03/22/2001 | WO2001019791A2 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments |